Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

ESMO Immuno-Oncology Congress 2023, 6-8 December 2023, Geneva, Switzerland

Ogkologos - 29 Νοεμβρίου, 2023

A Combination of Osimertinib Plus Pemetrexed and a Platinum-based Agent Significantly...

Ogkologos - 29 Νοεμβρίου, 2023

Qué debo saber sobre los programas de emparejamiento de ensayos clínicos...

Ogkologos - 28 Νοεμβρίου, 2023

Efficacy of Rituximab Maintenance in Patients with Mantle Cell Lymphoma Who...

Ogkologos - 28 Νοεμβρίου, 2023

EMA Recommends Extension of Indications for Talazoparib

Ogkologos - 27 Νοεμβρίου, 2023

ESMO Asia Congress 2023, 1-3 December 2023, Singapore

Ogkologos - 24 Νοεμβρίου, 2023

A Combination of Trastuzumab with Gemcitabine and Cisplatin Shows Promising Activity...

Ogkologos - 24 Νοεμβρίου, 2023

FDA Approves Capivasertib with Fulvestrant for Breast Cancer

Ogkologos - 23 Νοεμβρίου, 2023

How I’m Working to Erase the Stigma of Lung Cancer: A...

Ogkologos - 22 Νοεμβρίου, 2023

PET Positivity After Two Cycles of ABVD Is Associated with a...

Ogkologos - 22 Νοεμβρίου, 2023

1...101102103...440 Σελίδα 102 από 440

MOST POPULAR

FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

6 Νοεμβρίου, 2025

Hockey Fan Dubbed Hero After Saving Equipment Manager’s Life

9 Ιανουαρίου, 2022

Treatment Strategy for ecDNA-Driven Tumors Shows Potential

5 Δεκεμβρίου, 2024

Efficacy and Safety of Patritumab Deruxtecan in Patients with EGFR-mutated NSCLC...

29 Σεπτεμβρίου, 2023

Φόρτωση περισσοτέρων

ESMO Immuno-Oncology Congress 2023, 6-8 December 2023, Geneva, Switzerland

A Combination of Osimertinib Plus Pemetrexed and a Platinum-based Agent Significantly...

Qué debo saber sobre los programas de emparejamiento de ensayos clínicos...

Efficacy of Rituximab Maintenance in Patients with Mantle Cell Lymphoma Who...

EMA Recommends Extension of Indications for Talazoparib

ESMO Asia Congress 2023, 1-3 December 2023, Singapore

A Combination of Trastuzumab with Gemcitabine and Cisplatin Shows Promising Activity...

FDA Approves Capivasertib with Fulvestrant for Breast Cancer

How I’m Working to Erase the Stigma of Lung Cancer: A...

PET Positivity After Two Cycles of ABVD Is Associated with a...

MOST POPULAR

FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma

Hockey Fan Dubbed Hero After Saving Equipment Manager’s Life

Treatment Strategy for ecDNA-Driven Tumors Shows Potential

Efficacy and Safety of Patritumab Deruxtecan in Patients with EGFR-mutated NSCLC...

HOT NEWS

Doctor Wipes Away The Debt Of 200 Cancer Patients

Risk of Distant Recurrence of ER-Positive Breast Cancer in Premenopausal Women...

Breaking down the new standards for cancer care proposed by NHS...

Sacituzumab Govitecan Does Not Demonstrate a Statistically Significant OS Improvement in...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ